SAS Output

23-JAN-2018 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 180 18 12 7 4 1 0 07/25/2016 217 93
        2 Cabozantinib   15 9 6 3 1 0      
        3 Crizotinib   17 10 6 4 1 0      
        4 Savolitinib   17 12 5 4 2 0      
            67 43 24 15 5 0      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 22 22 17 7 2 1 02/24/2017 145 65
        2 Tokyo-172 BCG   21 21 16 8 2 1      
        3 Prime + Tokyo-172 BCG   21 21 17 9 2 1      
            64 64 50 24 6 3      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 148 30 30 24 15 3 2 03/13/2017 152 70
            30 30 24 15 3 2      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   2 1 0 0 0 0 11/23/2016 59 34
            2 1 0 0 0 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   7 7 7 4 1 0 09/29/2017   17
            7 7 7 4 1 0      
 
    1 E Total Registrations   6 6 6 3 1 0 09/29/2017    
            6 6 6 3 1 0      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   1 1 1 0 0 0 08/24/2017   103
            1 1 1 0 0 0      
 
    2 E Total Registrations   1 1 1 0 0 0 08/24/2017    
            1 1 1 0 0 0      
 
No EA8141-UTUC, HG, Chemo then Surg 1 E Total Registrations   8 2 0 0 0 0 02/23/2016 152 74
            8 2 0 0 0 0      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   64 28 17 9 3 2 11/25/2013   163
            64 28 17 9 3 2